Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa
Stellenbosch University · University of KwaZulu-Natal · +30 more institutions
Abstract
Three lineages (BA.1, BA.2 and BA.3) of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant of concern predominantly drove South Africa's fourth Coronavirus Disease 2019 (COVID-19) wave. We have now identified two new lineages, BA.4 and BA.5, responsible for a fifth wave of infections. The spike proteins of BA.4 and BA.5 are identical, and similar to BA.2 except for the addition of 69-70 deletion (present in the Alpha variant and the BA.1 lineage), L452R (present in the Delta variant), F486V and the wild-type amino acid at Q493. The two lineages differ only outside of the spike region. The 69-70 deletion in spike allows these lineages to be identified by the proxy marker of S-gene…
Citation impact
- FWCI
- 67.04
- Percentile
- 100%
- References
- 42
Authors
95- HTHouriiyah Tegally
Stellenbosch University, University of KwaZulu-Natal
- MMMonika Moir
Stellenbosch University
- JEJosie Everatt
National Health Laboratory Service
- MGMarta Giovanetti
Universidade Federal de Minas Gerais, Fundação Oswaldo Cruz
- CSCathrine Scheepers
National Health Laboratory Service, South African Medical Research Council, University of the Witwatersrand
Topics & keywords
- Biology
- Lineage (genetic)
- Biological dispersal
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- Coronavirus disease 2019 (COVID-19)
- Evolutionary biology
- Genetics
- Gene
- Good health and well-being
Funding
- BABill and Melinda Gates FoundationAward: INV-018978
- RFRockefeller FoundationAward: HTH 017
- WHWorld Health OrganizationAwards: SARS-CoV-2, COVID-19
- WWellcomeAward: 221003/Z/20/Z
- DODepartment of Science and Innovation, South Africa
- DODepartment of Health and Social Care
- SASouth African Medical Research CouncilAward: 2020/049
- UOUniversity of Pretoria
- FCForeign, Commonwealth and Development Office
- NINational Institutes of HealthAwards: U54 TW012041, 3D43TW009610-09S1, COVID-19, U01 AI151698, AI151698
- CFCenters for Disease Control and PreventionAwards: NU51IP000930, U01IP001048
- MRMedical Research CouncilAward: COVID-19
- NINational Institute of Allergy and Infectious DiseasesAwards: 5K24AI131924, COVID-19, U01 AI151698, 5K24AI131928, AI151698
- FIFogarty International Center
- CFCenter for Information TechnologyAward: U54 TW012041